These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Colchicine for primary biliary cirrhosis: a Cochrane Hepato-Biliary Group systematic review of randomized clinical trials. Gong Y; Gluud C Am J Gastroenterol; 2005 Aug; 100(8):1876-85. PubMed ID: 16086725 [TBL] [Abstract][Full Text] [Related]
26. Methotrexate for primary biliary cirrhosis. Gong Y; Gluud C Cochrane Database Syst Rev; 2005 Jul; (3):CD004385. PubMed ID: 16034929 [TBL] [Abstract][Full Text] [Related]
27. D-penicillamine for primary biliary cirrhosis. Gong Y; Frederiksen SL; Gluud C Cochrane Database Syst Rev; 2004 Oct; 2004(4):CD004789. PubMed ID: 15495127 [TBL] [Abstract][Full Text] [Related]
28. Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches. Royle P; Milne R Int J Technol Assess Health Care; 2003; 19(4):591-603. PubMed ID: 15095765 [TBL] [Abstract][Full Text] [Related]
31. The epidemiology of primary biliary cirrhosis. Prince MI; James OF Clin Liver Dis; 2003 Nov; 7(4):795-819. PubMed ID: 14594132 [TBL] [Abstract][Full Text] [Related]
32. Statistical aspects of the analysis of data from retrospective studies of disease. MANTEL N; HAENSZEL W J Natl Cancer Inst; 1959 Apr; 22(4):719-48. PubMed ID: 13655060 [No Abstract] [Full Text] [Related]
33. Quantifying heterogeneity in a meta-analysis. Higgins JP; Thompson SG Stat Med; 2002 Jun; 21(11):1539-58. PubMed ID: 12111919 [TBL] [Abstract][Full Text] [Related]
34. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Kjaergard LL; Villumsen J; Gluud C Ann Intern Med; 2001 Dec; 135(11):982-9. PubMed ID: 11730399 [TBL] [Abstract][Full Text] [Related]
35. Histological patterns of rejection using oral microemulsified cyclosporine and tacrolimus (FK506) as monotherapy induction after orthotopic liver transplantation. Chau TN; Quaglia A; Rolles K; Burroughs AK; Dhillon AP Liver; 2001 Oct; 21(5):329-34. PubMed ID: 11589769 [TBL] [Abstract][Full Text] [Related]
36. Evolution of treatment effects over time: empirical insight from recursive cumulative metaanalyses. Ioannidis J; Lau J Proc Natl Acad Sci U S A; 2001 Jan; 98(3):831-6. PubMed ID: 11158556 [TBL] [Abstract][Full Text] [Related]
37. Epidemiology and natural history of primary biliary cirrhosis in a US community. Kim WR; Lindor KD; Locke GR; Therneau TM; Homburger HA; Batts KP; Yawn BP; Petz JL; Melton LJ; Dickson ER Gastroenterology; 2000 Dec; 119(6):1631-6. PubMed ID: 11113084 [TBL] [Abstract][Full Text] [Related]
38. Prescribing habits in primary biliary cirrhosis: a national survey. Verma A; Jazrawi RP; Ahmed HA; Northfield TC Eur J Gastroenterol Hepatol; 1999 Aug; 11(8):817-20. PubMed ID: 10514110 [TBL] [Abstract][Full Text] [Related]
39. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Moher D; Pham B; Jones A; Cook DJ; Jadad AR; Moher M; Tugwell P; Klassen TP Lancet; 1998 Aug; 352(9128):609-13. PubMed ID: 9746022 [TBL] [Abstract][Full Text] [Related]